Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
nor-Binaltorphimine dihydrochloride in OIH Assays
2026-09-08
Use nor-Binaltorphimine dihydrochloride to test whether κ-opioid receptor signaling causally contributes to opioid-induced mechanical hypersensitivity, tolerance, and circuit-level pain responses. This workflow connects controlled antagonist assays with receptor pharmacology, spinal pathway experiments, and reproducible behavioral readouts.
-
HyperScribe™ Poly (A) Tailing Kit Guide
2026-09-08
The HyperScribe™ Poly (A) Tailing Kit uses E. coli Poly (A) Polymerase to add a polyadenylate tail of at least 150 bases to compatible in vitro transcribed RNA. The workflow supports research applications that require enhanced mRNA stability and translation efficiency, including transfection experiments, but the product specification does not establish a universal effect across cell types or RNA designs.
-
Fenofibrate, Aging, and the PPARα–YAP Axis
2026-09-07
A 2025 study shows that Fenofibrate produces comparable liver enlargement and PPARα–YAP pathway activation in adult and aging mice. Its multi-model design suggests that age does not substantially eliminate this hepatic response, while also defining important limits for translating mouse liver phenotypes to human therapy or cancer biology.
-
Tetrahedral DNA Frameworks Improve Enzymatic Synthesis
2026-09-07
The reference study introduces tetrahedral DNA nanostructures as ordered interfaces that improve primer presentation, enzyme accessibility, and reaction performance in enzymatic oligonucleotide synthesis. The framework reduced deletion errors in patterned sequences and enabled a 60-nucleotide information-storage construct with a reported 96.82% stepwise yield.
-
Dovitinib and Radiopathomics in Translational Oncology
2026-09-05
Dovitinib offers a mechanistically rich way to interrogate RTK-driven cancer biology, while radiopathomics provides a complementary strategy for mapping treatment-response heterogeneity. Together, they support a more disciplined translational framework that connects pathway inhibition, tumor phenotype, and biomarker development without overstating evidence.
-
Live-Dead Cell Staining Kit I: Assay Strategy
2026-09-04
Discover how the Live-Dead Cell Staining Kit I converts membrane integrity and intracellular esterase activity into interpretable mammalian cell viability data. This guide applies Calcein AM/PI staining to hypoxia-activated photomolecular glue studies while clarifying controls, limitations, and orthogonal validation.
-
Ellagic acid for CK2 and Senescence Workflows
2026-09-04
Ellagic acid provides a practical chemical probe for connecting CK2 activity with cancer-cell signaling, oxidative stress, apoptosis, and senescence-oriented assays. This guide translates the reference study’s machine-learning strategy into controlled bench workflows while emphasizing solvent handling, orthogonal readouts, and interpretation limits.
-
MiR-519d-3p Exosomes in Preeclampsia Immunity
2026-09-03
This 2025 study links placenta-derived exosomal miR-519d-3p with altered T-cell behavior in preeclampsia, including increased Jurkat T-cell proliferation, reduced apoptosis, and a shift toward Th17 differentiation. Its combination of sequencing and cell-based validation provides a mechanistic framework for studying how fetal trophoblast signals may disrupt maternal–fetal immune tolerance.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-03
The Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, provides a research reagent for detecting HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for controlled scientific workflows only; the supplied dossier does not establish diagnostic, therapeutic, or application-specific performance beyond the listed uses.
-
2'3'-cGAMP: Practical STING Assay Workflows
2026-09-02
Build reproducible cGAS-STING experiments with 2'3'-cGAMP (sodium salt), from water-based stock preparation to endothelial and immune-cell readouts. This workflow emphasizes cell-specific signaling, type I interferon induction, assay controls, and troubleshooting for immunotherapy research.
-
(R,S)-Anatabine Workflows for Aβ Research
2026-09-02
(R,S)-Anatabine supports mechanism-led Alzheimer’s workflows that connect soluble Aβ peptide reduction with APP processing, BACE-1 expression, and NF-κB signaling. This guide translates those properties into practical in vitro and in vivo study designs, with handling parameters and troubleshooting checkpoints for reproducible neurodegeneration research.
-
STAU2 Condensates Tune Neuronal RNA Control
2026-09-01
This Advanced Science study identifies STAU2 phase separation as a dynamic control system for dendritic mRNA transport, storage, and activity-dependent translation. Its central insight is that both insufficient and excessive condensation disrupt neuronal development, establishing condensate material state and size as critical variables in RNA regulation.
-
CARMIL MB Domain Links Membranes to Actin Assembly
2026-09-01
Mooren and colleagues show that the CARMIL membrane-binding domain does more than localize capping protein: it recruits the CPI and CSI regulatory motifs to membranes, promotes CP-dependent actin assembly, and can disengage after CP binding. The findings provide a mechanistic explanation for how membrane-associated CARMIL may activate capping protein while enabling subsequent actin assembly near the plasma membrane.
-
NETs Activate cGAS–STING in Surgical Brain Injury
2026-08-31
A 2024 rat study identifies neutrophil extracellular traps (NETs) as upstream drivers of surgical brain injury through activation of the cGAS–STING pathway. NET disruption reduced inflammation, edema, neuronal death, and neurological impairment, while cGAMP restored pathway activity and weakened the protective effect of DNase I.
-
KPT-330: CRM1 Inhibition Beyond Cancer
2026-08-31
KPT-330 (Selinexor) is a selective CRM1 inhibitor best known for oncology research, but new evidence extends its relevance to osteoclast-driven osteoarthritis. This article connects nuclear export biology with bone-cartilage remodeling and translates the findings into practical assay decisions.